[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU8691398A - Methods for identifying ligand specific binding molecules - Google Patents

Methods for identifying ligand specific binding molecules

Info

Publication number
AU8691398A
AU8691398A AU86913/98A AU8691398A AU8691398A AU 8691398 A AU8691398 A AU 8691398A AU 86913/98 A AU86913/98 A AU 86913/98A AU 8691398 A AU8691398 A AU 8691398A AU 8691398 A AU8691398 A AU 8691398A
Authority
AU
Australia
Prior art keywords
methods
specific binding
binding molecules
ligand specific
identifying ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU86913/98A
Inventor
William D. Huse
Jeffry D. Watkins
Herren Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Molecular Evolution Inc
Original Assignee
Ixsys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ixsys Inc filed Critical Ixsys Inc
Publication of AU8691398A publication Critical patent/AU8691398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
AU86913/98A 1997-08-04 1998-08-04 Methods for identifying ligand specific binding molecules Abandoned AU8691398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90582597A 1997-08-04 1997-08-04
US08905825 1997-08-04
PCT/US1998/016280 WO1999006834A2 (en) 1997-08-04 1998-08-04 Methods for identifying ligand specific binding molecules

Publications (1)

Publication Number Publication Date
AU8691398A true AU8691398A (en) 1999-02-22

Family

ID=25421544

Family Applications (1)

Application Number Title Priority Date Filing Date
AU86913/98A Abandoned AU8691398A (en) 1997-08-04 1998-08-04 Methods for identifying ligand specific binding molecules

Country Status (3)

Country Link
EP (1) EP1007967A2 (en)
AU (1) AU8691398A (en)
WO (1) WO1999006834A2 (en)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020146740A1 (en) * 1997-10-09 2002-10-10 William D. Huse Method for identifying optimal binding ligands to a receptor
AU1449499A (en) 1997-10-31 1999-05-24 Maxygen, Incorporated Modification of virus tropism and host range by viral genome shuffling
CA2386791A1 (en) 1999-10-08 2001-04-19 Protogene Laboratories, Inc. Method and apparatus for performing large numbers of reactions using array assembly
SE9903895D0 (en) 1999-10-28 1999-10-28 Active Biotech Ab Novel compounds
GB0008419D0 (en) * 2000-04-05 2000-05-24 Bioinvent Int Ab A method for invitro molecular evolution of antibody function
US8288322B2 (en) 2000-04-17 2012-10-16 Dyax Corp. Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
DK1276855T3 (en) 2000-04-17 2012-11-26 Dyax Corp Method of constructing display libraries of genetic packages for members of a diversified peptide family
ES2430857T3 (en) 2000-12-18 2013-11-22 Dyax Corp. Targeted libraries of genetic packages
US7365167B2 (en) 2001-11-26 2008-04-29 Cell Matrix, Inc. Humanized collagen antibodies and related methods
US7390885B2 (en) 2001-11-26 2008-06-24 Cell Matrix, Inc. Humanized collagen antibodies and related methods
US20040067532A1 (en) 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
US7612181B2 (en) 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
AU2006329208B2 (en) 2005-12-23 2012-03-08 Viventia Bio Inc. Methods for generating and screening fusion protein libraries and uses thereof
BRPI0716438B1 (en) 2006-09-08 2022-01-25 Abbvie Bahamas Ltd il-13 binding proteins, recombinant anti-il-13 antibody, antibody construct, pharmaceutical compositions and uses thereof to reduce il-13 biological activity and function and treat respiratory disorders
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
AU2008298603B2 (en) 2007-09-14 2015-04-30 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
WO2009055656A2 (en) 2007-10-26 2009-04-30 Centocor, Inc. Vectors, host cells, and methods of production and uses
US9873957B2 (en) 2008-03-13 2018-01-23 Dyax Corp. Libraries of genetic packages comprising novel HC CDR3 designs
JP5780951B2 (en) 2008-04-24 2015-09-16 ダイアックス コーポレーション A library of genetic packages containing new HCCR1, CDR2 and CDR3 designs, and new LCCR1, CDR2 and CDR3 designs
NZ588554A (en) 2008-04-29 2013-03-28 Abbott Lab Dual variable domain immunoglobulins and uses thereof
RU2518351C2 (en) 2008-05-09 2014-06-10 Эббви Дойчланд Гмбх Унд Ко.Кг, Advanced glycation end product (rage) receptor antibodies and using them
JP2011523853A (en) 2008-06-03 2011-08-25 アボット・ラボラトリーズ Dual variable domain immunoglobulins and uses thereof
CA2725666A1 (en) 2008-06-03 2009-12-10 Abbott Laboratories Dual variable domain immunoglobulins and uses thereof
MX2010014574A (en) 2008-07-08 2011-04-27 Abbott Lab Prostaglandin e2 dual variable domain immunoglobulins and uses thereof.
MX2011009362A (en) 2009-03-05 2011-09-26 Abbott Lab Il-17 binding proteins.
SG178930A1 (en) 2009-08-29 2012-04-27 Abbott Lab Therapeutic dll4 binding proteins
US8586714B2 (en) 2009-09-01 2013-11-19 Abbvie, Inc. Dual variable domain immunoglobulins and uses thereof
TW201119676A (en) 2009-10-15 2011-06-16 Abbott Lab Dual variable domain immunoglobulins and uses thereof
UY32979A (en) 2009-10-28 2011-02-28 Abbott Lab IMMUNOGLOBULINS WITH DUAL VARIABLE DOMAIN AND USES OF THE SAME
WO2011053707A1 (en) 2009-10-31 2011-05-05 Abbott Laboratories Antibodies to receptor for advanced glycation end products (rage) and uses thereof
AU2011223919B2 (en) 2010-03-02 2015-03-19 Abbvie Inc. Therapeutic DLL4 binding proteins
SG185502A1 (en) 2010-05-14 2012-12-28 Abbvie Inc Il-1 binding proteins
US9354228B2 (en) 2010-07-16 2016-05-31 Adimab, Llc Antibody libraries
CN103298834A (en) 2010-08-03 2013-09-11 Abbvie公司 Dual variable domain immunoglobulins and uses thereof
DK3333188T3 (en) 2010-08-19 2022-03-07 Zoetis Belgium S A Anti-NGF antibodies and their use
WO2012027570A2 (en) 2010-08-26 2012-03-01 Abbott Laboratories Dual variable domain immunoglobulins and uses thereof
TW201307388A (en) 2010-12-21 2013-02-16 Abbott Lab IL-1 binding proteins
JP2014533659A (en) 2011-10-24 2014-12-15 アッヴィ・インコーポレイテッド Immunobinder for sclerostin
UY34558A (en) 2011-12-30 2013-07-31 Abbvie Inc DUAL SPECIFIC UNION PROTEINS DIRECTED AGAINST IL-13 AND / OR IL-17
CN104364264B (en) 2012-06-06 2018-07-24 硕腾服务有限责任公司 Dog source anti-ngf antibodies and its method
WO2014011955A2 (en) 2012-07-12 2014-01-16 Abbvie, Inc. Il-1 binding proteins
RU2668824C2 (en) 2012-08-31 2018-10-02 Иммьюноджен Инк. Diagnostic assays and kits for detection of folate receptor 1
KR20190107184A (en) 2012-11-01 2019-09-18 애브비 인코포레이티드 Anti-vegf/dll4 dual variable domain immunoglobulins and uses thereof
WO2014100542A1 (en) 2012-12-21 2014-06-26 Abbvie, Inc. High-throughput antibody humanization
CA2906417C (en) 2013-03-14 2022-06-21 Robert Ziemann Hcv core lipid binding domain monoclonal antibodies
US9790478B2 (en) 2013-03-14 2017-10-17 Abbott Laboratories HCV NS3 recombinant antigens and mutants thereof for improved antibody detection
US9194873B2 (en) 2013-03-14 2015-11-24 Abbott Laboratories HCV antigen-antibody combination assay and methods and compositions for use therein
JP2016522793A (en) 2013-03-15 2016-08-04 アッヴィ・インコーポレイテッド Bispecific binding protein directed against IL-1β and / or IL-17
GB201406767D0 (en) 2014-04-15 2014-05-28 Cancer Rec Tech Ltd Humanized anti-Tn-MUC1 antibodies anf their conjugates
US10093733B2 (en) 2014-12-11 2018-10-09 Abbvie Inc. LRP-8 binding dual variable domain immunoglobulin proteins
TW201710286A (en) 2015-06-15 2017-03-16 艾伯維有限公司 Binding proteins against VEGF, PDGF, and/or their receptors
CA3027045A1 (en) 2016-06-08 2017-12-14 Abbvie Inc. Anti-b7-h3 antibodies and antibody drug conjugates
CA3044244A1 (en) 2016-11-16 2018-05-24 Janssen Biotech, Inc. Method of treating psoriasis with anti-il23 specific antibody
US10899842B2 (en) 2016-11-23 2021-01-26 Immunoah Therapeutics, Inc. 4-1BB binding proteins and uses thereof
US11390685B2 (en) 2017-01-06 2022-07-19 Biosion, Inc. ErbB2 antibodies and uses therefore
MX2019008989A (en) 2017-01-30 2019-10-09 Janssen Biotech Inc Anti-tnf antibodies, compositions, and methods for the treatment of active psoriatic arthritis.
KR20240038148A (en) 2017-02-07 2024-03-22 얀센 바이오테크 인코포레이티드 Anti-tnf antibodies, compositions, and methods for the treatment of active ankylosing spondylitis
EP3625254B1 (en) 2017-07-31 2023-12-13 F. Hoffmann-La Roche AG Three-dimensional structure-based humanization method
TW201922780A (en) 2017-09-25 2019-06-16 美商健生生物科技公司 Safe and effective method of treating Lupus with anti-IL12/IL23 antibody
EP3694552A1 (en) 2017-10-10 2020-08-19 Tilos Therapeutics, Inc. Anti-lap antibodies and uses thereof
SG11202007702UA (en) 2018-02-14 2020-09-29 Viela Bio Inc Antibodies to feline mcdonough sarcoma (fms)-like tyrosine kinase 3 receptor ligand (flt3l) and uses thereof for treating autoimmune and inflammatory diseases
WO2019171252A1 (en) 2018-03-05 2019-09-12 Janssen Biotech, Inc. Methods of treating crohn's disease with anti-il23 specific antibody
EP3765499A1 (en) 2018-03-12 2021-01-20 Zoetis Services LLC Anti-ngf antibodies and methods thereof
EP3824295A4 (en) 2018-07-18 2022-04-27 Janssen Biotech, Inc. Sustained response predictors after treatment with anti-il23 specific antibody
BR112021005467A2 (en) 2018-09-24 2021-06-22 Janssen Biotech, Inc. safe and effective method to treat ulcerative colitis with anti-il12/il23 antibody
WO2020076969A2 (en) 2018-10-10 2020-04-16 Tilos Therapeutics, Inc. Anti-lap antibody variants and uses thereof
CN113395979A (en) 2018-11-20 2021-09-14 詹森生物科技公司 Safe and effective methods for treating psoriasis with anti-IL-23 specific antibodies
US20200197517A1 (en) 2018-12-18 2020-06-25 Janssen Biotech, Inc. Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody
EP3938391A1 (en) 2019-03-14 2022-01-19 Janssen Biotech, Inc. Methods for producing anti-tnf antibody compositions
KR20210141998A (en) 2019-03-14 2021-11-23 얀센 바이오테크 인코포레이티드 Method of making anti-TNF antibody composition
JP2022525145A (en) 2019-03-14 2022-05-11 ヤンセン バイオテツク，インコーポレーテツド A production method for producing an anti-IL12 / IL23 antibody composition.
MX2021011328A (en) 2019-03-18 2021-12-10 Janssen Biotech Inc Method of treating psoriasis in pediatric subjects with anti-il12/il23 antibody.
EP3972690A4 (en) 2019-05-23 2023-07-05 Janssen Biotech, Inc. Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha
UY39610A (en) 2021-01-20 2022-08-31 Abbvie Inc ANTI-EGFR ANTIBODY-DRUG CONJUGATES
EP4308603A1 (en) 2021-03-17 2024-01-24 Receptos Llc Methods of treating atopic dermatitis with anti il-13 antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94872A (en) * 1989-06-30 1995-03-30 Oncogen Monoclonal or chimeric antibodies reactive with human carcinomas, recombinant proteins comprising their antigen binding region, pharmaceutical compositions and kits comprising said antibodies and methods for imaging human carcinoma using same
GB9317423D0 (en) * 1993-08-21 1993-10-06 Imp Cancer Res Tech Monoclonal antibodies
US5639863A (en) * 1994-06-21 1997-06-17 Dan; Michael D. Human monoclonal antibodies specific to cell cycle independent glioma surface antigen
US5792456A (en) * 1994-08-04 1998-08-11 Bristol-Myers Squibb Company Mutant BR96 antibodies reactive with human carcinomas

Also Published As

Publication number Publication date
EP1007967A2 (en) 2000-06-14
WO1999006834A2 (en) 1999-02-11
WO1999006834A3 (en) 1999-05-14

Similar Documents

Publication Publication Date Title
AU8691398A (en) Methods for identifying ligand specific binding molecules
AU5752696A (en) Dna binding antibodies
AU2662795A (en) Cdk4 binding proteins
AU4983497A (en) Reagent strip slide stainer
AU2035199A (en) Method for organizing information
AU8275998A (en) Rapid flow-through binding assay apparatus and method
AU1275899A (en) Methods for preparing polynucleotide transfection complexes
AU4028800A (en) Method for identifying accessible binding sites on rna
AU4072095A (en) Automated system for identifying authorized system users
GB9722032D0 (en) Identifying substances
AU3961897A (en) Methods for identifying vasoprotective agents
AU9109898A (en) Automated auditing system
AU5587799A (en) Protein transport-associated molecules
AU3568799A (en) Booklet
GB2327204B (en) Binding apparatus
AUPP298498A0 (en) Matrix binding factor
AU4550896A (en) New DNA molecules
EP0808375A4 (en) Lil-stat dna binding sites and methods for identifying inhibitory binding agents
AU7958498A (en) Carpet sample book
AU5384596A (en) Binding assembly
AU3166897A (en) Factor vii-binding reagent
AU9796698A (en) Method for identifying optimal binding ligands to a receptor
AU1386599A (en) Methods for identifying biological macromolecule interactions with compounds
AU4586497A (en) Calcium-integrin binding protein
AU9227498A (en) File system block sub-allocator

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase